Acute and chronic pain associated with leprosy

Pain

Volumn 156, Issue 6, 2015, Pages 998-1002

  Thakur, Siddarth ^a   Dworkin, Robert H ^b   Haroun, Omer M O ^c   Lockwood, Diana N J ^c   Rice, Andrew S C ^d,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC INFLAMMATORY PAIN; CHRONIC NEUROPATHIC PAIN; CHRONIC PAIN; HUMAN; LEPROSY; MIXED PAIN; NEUROPATHIC PAIN; PRIORITY JOURNAL; REVIEW; CLASSIFICATION; COMPLICATION; PAIN;

HUMANS; LEPROSY; PAIN;

EID: 84943172854     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000178     Document Type: Review

References (44)

1. Atkin S, El-Ghobarey A, KamelM, Owen J, Dick W. Clinical and laboratory studies of arthritis in leprosy. BMJ 1989;298:1423-5.
2. Baron R, Binder A. How neuropathic is sciatica? Themixed pain concept. Orthopade 2004;33:568-75.
3. Britton WJ. The management of leprosy reversal reactions. Lepr Rev 1998;69:225-34.
4. Britton WJ, Lockwood DNJ. Leprosy. Lancet 2004;363:1209-19.
5. Chen S, Qu J, Chu T. Prevalence and characteristics of neuropathic pain in the people affected by leprosy in China. Lepr Rev 2012;83:195-201.
6. Cossermelli-Messina W, Festa NC, Cossermelli W. Articular inflammatory manifestations in patients with different forms of leprosy. J Rheumatol 1998;25:111-9.
7. Dworkin RH, Turk DC, Basch E, Berger A, Cleeland C, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Markman J, Porter L, Raja SN, Ross E, Todd K, Wallace M, Woolf CJ. Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. PAIN 2011;152:1705-8.
8. Eichelmann K, Gonzalez SE, Salas-Alanis JC, Ocampo-Candiani J. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr 2013;104:554-63.
9. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpaia M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice ASC, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14:162-73.
10. Haanpaia M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, Cruccu G, Hansson P, Haythornthwaite JA, Iannetti GD, Jensen TS, Kauppila T, Nurmikko TJ, Rice AS, Rowbotham M, Serra J, Sommer C, Smith BH, Treede RD. NeuPSIG guidelines on neuropathic pain assessment. PAIN 2011;152:14-27.
11. Haanpaia M, Lockwood DNJ, Hietaharju A. Neuropathic pain in leprosy. Lepr Rev 2004;75:7-18.
12. Haroun OM, Hietaharju A, Bizuneh E, Tesfaye F, Brandsma JW, Haanpaia M, Rice AS, Lockwood DNJ. Investigation of neuropathic pain in treated leprosy patients in Ethiopia: a cross-sectional study. PAIN 2012;153: 1620-4.
13. Hietaharju A, Croft R, Alam R, Birch P, Mong A, Haanpaia M. Chronic neuropathic pain in treated leprosy. Lancet 2000;356:1080-1.
14. Ishikawa A, Ishikawa S, Hirakawa M. Osteoporosis, bone turnover and hypogonadism in elderly men with treated leprosy. Lepr Rev 2001;72: 322-9.
15. Jakeman P, Smith W. Thalidomide in leprosy reaction. Lancet 1994;343: 432-3.
16. Jensen TS, Baron R, Haanpaia M, Kalso E, Loeser JD, Rice AS, Treede RD. A new definition of neuropathic pain. PAIN 2011;152:2204-5.
17. Kamerman P, Wadley A, Davis K, Hietaharju A, Jain PN, Kopf A, Meyer AC, RajaSN,RiceASC,SmithBH,TreedeRD,WiffenP.WorldHealthOrganization (WHO) essentialmedicines lists: where are the drugs to treat neuropathic pain? PAIN 2014. In press. DOI: 10.1097/01.j.pain.0000460356.94374.a1.
18. Lasry-Levy E, Hietaharju A, Pai V, Ganapati R, Rice AS, Haanpaia M, Lockwood DNJ. Neuropathic pain and psychological morbidity in patients with treated leprosy: a cross-sectional prevalence study in Mumbai. PLoS Negl Trop Dis 2011;5:e981.
19. Lockwood DNJ. Leprosy. Medicine 2005;33:26-9.
20. Lockwood DNJ, Shetty V, Penna GO. Hazards of setting targets to eliminate disease: lessons from the leprosy elimination campaign. BMJ 2014;348:g1136.
21. Lund C, Koskinen M, Suneetha S, Lockwood DNJ, Haanpaia M, Haapasalo H, Hietaharju A. Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India. Lepr Rev 2007;78:369-80.
22. Malaviya G. Neuropathic pain in leprosy patients. Int J Lepr Other Mycobact Dis 2005;73:34-5.
23. Manandhar R, Shrestha N, Butlin C, Roche P. High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy. Clin Exp Immunol 2002;128:333-8.
24. Mandal SK, Sarkar RN, Sarkar P, Datta S, Bandyopadhyay R, Bandyopadhyay D, Pain S. Rheumatological manifestations of leprosy. J Indian Med Assoc 2008;106:165-6.
25. Nations SP, Katz JS, Lyde CB, Barohn RJ. Leprous neuropathy: an American perspective. Semin Neurol 1998;18:113-24.
26. Noordeen SK. Epidemiology of leprosy. In: Gangadharam PRJ, Jenkins PA, editors. Mycobacteria: basic aspects. New York: Chapman & Hall, 1998. p. 379-97.
27. Pereira HL, Ribeiro SL, Pennini SN, Sato EI. Leprosy-related joint involvement. Clin Rheumatol 2009;28:79-84.
28. Prasad S, Misra R, Aggarwal A, Lawrence A, Haroon N, Wakhlu A, Krishnani N, Agrawal V, Paliwal VK, Jha S. Leprosy revealed in a rheumatology clinic: a case series. Int J Rheum Dis 2013;16:129-33.
29. Ramos JM, Alonso-Castaneda B, Eshetu D, Lemma D, Reyes F, Belinchon I, Gorgolas M. Prevalence and characteristics of neuropathic pain in leprosy patients treated years ago. Pathog Glob Health 2014;108: 186-90.
30. Reis FJJ, Saadi L, Gomes MK, Gosling AP, Cunha A. Pain in leprosy patients: shall we always consider as a neural damage? Lepr Rev 2011; 82:319-21.
31. Reis FJJ, Gomes MK, Rodrigues J, Gosling AP, Fontana AP, Cunha AJLA. Pain and its consequences in quality of life: a study with WHOQOL-Bref in leprosy patients with neuropathic pain. ISRN Trop Med 2013:http://dx.doi.org/10.1155/2013/987683.
32. Ridley D, Jopling W. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966;34:255-73.
33. Sabin TD. Temperature-linked sensory loss: a unique pattern in leprosy. Arch Neurol 1969;20:257-62.
34. Salvi S, Chopra A. Leprosy in a rheumatology setting: a challenging mimic to expose. Clin Rheumatol 2013;32:1557-63.
35. Saunderson P, Bizuneh E, Leekassa R. Neuropathic pain in people treated for multibacillary leprosy more than ten years previously. Lepr Rev 2008;79:270-6.
36. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev 2006;19: 338-81.
37. Stump PR, Baccarelli R, Marciano L, Lauris JR, Teixeira MJ, Ura S, Virmond MC. Neuropathic pain in leprosy patients. Int J Lepr Other Mycobact Dis 2004;72:134-8.
38. Treede RD, Jensen TS, Campbell J, Cruccu G, Dostrovsky J, Griffin J, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5.
39. Truini A, Barbanti P, Pozzilli C, Cruccu G. A mechanism-based classification of pain in multiple sclerosis. J Neurol 2013;260:351-67.
40. van Brakel WH, Nicholls PG, Wilder-Smith EP, Das L, Barkataki P, Lockwood DNJ, Group IS. Early diagnosis of neuropathy in leprosy?comparing diagnostic tests in a large prospective study (the INFIR cohort study). PLoS Negl Trop Dis 2008;2:e212.
41. Vengadakrishnan K, Saraswat P, Mathur P. A study of rheumatological manifestations of leprosy. Indian J Dermatol Venereol Leprol 2004;70: 76-8.
42. WHO. Global leprosy situation, 2012. Wkly Epidemiol Rec 2012;34: 317-28. Available at: http://www.who.int/wer/2012/wer8734/en. Accessed April 19, 2014.
43. WHO. Expert Committee on Leprosy: seventh report.WHOTech Rep Ser 1998;874:1-43. Available at: http://www.who.int/iris/handle/10665/ 42060. Accessed April 19, 2014.
44. Wilson DJ. Insights from genomics into bacterial pathogen populations. PLoS Pathog 2012;8:e1002874.